1: Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virother. 2018 May 3;7:43-51. doi: 10.2147/OV.S155946. eCollection 2018. PubMed PMID: 29765912; PubMed Central PMCID: PMC5939883.
2: Zhang W, Fu J, Ehrhardt A. Novel vector construction based on alternative adenovirus types via homologous recombination. Hum Gene Ther Methods. 2018 May 14. doi: 10.1089/hgtb.2018.044. [Epub ahead of print] PubMed PMID: 29756505.
3: Jung SY, Kang KW, Lee EY, Seo DW, Kim HL, Kim H, Kwon T, Park HL, Kim H, Lee SM, Nam JH. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018 May 5. pii: S0264-410X(18)30598-X. doi: 10.1016/j.vaccine.2018.04.082. [Epub ahead of print] PubMed PMID: 29739720.
4: Li P, Feng F, Pan E, Fan X, Yang Q, Guan M, Chen L, Sun C. Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection. Virology. 2018 Apr 19;519:86-98. doi: 10.1016/j.virol.2018.04.005. [Epub ahead of print] PubMed PMID: 29680370.
5: Metcalfe HJ, Biffar L, Steinbach S, Guzman E, Connelley T, Morrison I, Vordermeier HM, Villarreal-Ramos B. Ag85A-specific CD4(+) T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties. Vaccine. 2018 May 11;36(20):2850-2854. doi: 10.1016/j.vaccine.2018.03.068. Epub 2018 Apr 11. PubMed PMID: 29655632; PubMed Central PMCID: PMC5937909.
6: Lapuente D, Ruzsics Z, Thirion C, Tenbusch M. Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses. Vaccine. 2018 May 3;36(19):2712-2720. doi: 10.1016/j.vaccine.2018.02.075. Epub 2018 Apr 5. PubMed PMID: 29628150.
7: Webber HC, Bermudez JY, Millar JC, Mao W, Clark AF. The Role of Wnt/β-Catenin Signaling and K-Cadherin in the Regulation of Intraocular Pressure. Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1454-1466. doi: 10.1167/iovs.17-21964. PubMed PMID: 29625468; PubMed Central PMCID: PMC5858463.
8: Deng Y, Lan J, Bao L, Huang B, Ye F, Chen Y, Yao Y, Wang W, Qin C, Tan W. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 4;7(1):60. doi: 10.1038/s41426-018-0056-7. PubMed PMID: 29618723; PubMed Central PMCID: PMC5884803.
9: Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J, Keith B, Young RM, Engels B, Sorsa S, Siurala M, Havunen R, Tähtinen S, Hemminki A, June CH. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018 Apr 5;3(7). pii: 99573. doi: 10.1172/jci.insight.99573. [Epub ahead of print] PubMed PMID: 29618658; PubMed Central PMCID: PMC5928866.
10: Guo Q, Chan JF, Poon VK, Wu S, Chan CC, Hou L, Yip CC, Ren C, Cai JP, Zhao M, Zhang AJ, Song X, Chan KH, Wang B, Kok KH, Wen Y, Yuen KY, Chen W. Immunization with a Novel Human type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. J Infect Dis. 2018 Mar 29. doi: 10.1093/infdis/jiy187. [Epub ahead of print] PubMed PMID: 29617816.
11: Wang X, Wang L, Xu Y, Zhang G, Wu Y, Chen P. PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment. Oncol Lett. 2018 Mar;15(3):3828-3837. doi: 10.3892/ol.2018.7811. Epub 2018 Jan 16. PubMed PMID: 29556278; PubMed Central PMCID: PMC5843999.
12: Pancholi NJ, Weitzman MD. Serotype-specific restriction of wild-type adenoviruses by the cellular Mre11-Rad50-Nbs1 complex. Virology. 2018 May;518:221-231. doi: 10.1016/j.virol.2018.02.023. Epub 2018 Mar 15. PubMed PMID: 29547809; PubMed Central PMCID: PMC5911183.
13: Raychaudhuri U, Millar JC, Clark AF. Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma? Exp Eye Res. 2018 Mar 10;171:106-110. doi: 10.1016/j.exer.2018.03.009. [Epub ahead of print] PubMed PMID: 29535003.
14: Baraniak I, Kropff B, McLean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, Mach M, Griffiths PD, Reeves MB. Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia. J Infect Dis. 2018 Mar 8. doi: 10.1093/infdis/jiy102. [Epub ahead of print] PubMed PMID: 29528415.
15: Blass E, Aid M, Martinot AJ, Larocca RA, Kang ZH, Badamchi-Zadeh A, Penaloza-MacMaster P, Reeves RK, Barouch DH. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018 May 14;92(11). pii: e02103-17. doi: 10.1128/JVI.02103-17. Print 2018 Jun 1. PubMed PMID: 29514912.
16: Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, Michael N, Hu H. Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 Feb 23;14(2):e1006888. doi: 10.1371/journal.ppat.1006888. eCollection 2018 Feb. PubMed PMID: 29474461; PubMed Central PMCID: PMC5841825.
17: Liu Z, Sun X, Xiao S, Lin Y, Li C, Hao N, Zhou M, Deng R, Ke S, Zhong Z. Characterization of aptamer-mediated gene delivery system for liver cancer therapy. Oncotarget. 2017 Dec 21;9(6):6830-6840. doi: 10.18632/oncotarget.23564. eCollection 2018 Jan 23. PubMed PMID: 29467932; PubMed Central PMCID: PMC5805518.
18: Harmon AW, Moitra R, Xu Z, Byrnes AP. Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum. PLoS One. 2018 Feb 5;13(2):e0192353. doi: 10.1371/journal.pone.0192353. eCollection 2018. PubMed PMID: 29401488; PubMed Central PMCID: PMC5798830.
19: Tutykhina I, Esmagambetov I, Bagaev A, Pichugin A, Lysenko A, Shcherbinin D, Sedova E, Logunov D, Shmarov M, Ataullakhanov R, Naroditsky B, Gintsburg A. Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts. PLoS One. 2018 Jan 29;13(1):e0191574. doi: 10.1371/journal.pone.0191574. eCollection 2018. PubMed PMID: 29377916; PubMed Central PMCID: PMC5788337.
20: Kiener R, Fleischmann M, Schwegler C, Ruzsics Z, Thirion C, Schrödel S, Asbach B, Wagner R. Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo. Sci Rep. 2018 Jan 24;8(1):1474. doi: 10.1038/s41598-018-19874-1. PubMed PMID: 29367743; PubMed Central PMCID: PMC5784015.